Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K1 | Q92918 | 7/20 | 0.78 |
| ▸ | IL2 | P60568 | 4/20 | 0.78 |
| ▸ | MAP3K11 | Q16584 | 1/20 | 0.70 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.61 |
| ▸ | KIT | P10721 | 3/20 | 0.58 |
| ▸ | TNIK | Q9UKE5 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21592574 | 0.89 | MAP4K1 (0.78) | MAP4K1IL2MAP3K11DYRK1AKIT | |
| SCHEMBL21592600 | 0.86 | MAP3K11 (0.66) | MAP4K1IL2MAP3K11DYRK1AKIT | |
| SCHEMBL15833785 | 0.83 | KIT (0.81) | MAP3K11DYRK1AKITTNIK | |
| SCHEMBL12066038 | 0.82 | MAP3K11 (1.00) | MAP4K1MAP3K11TNIK | |
| SCHEMBL21592636 | 0.81 | MAP4K1 (0.63) | MAP4K1IL2MAP3K11TNIK | |
| SCHEMBL21592616 | 0.80 | MAP4K1 (0.65) | MAP4K1IL2MAP3K11DYRK1AKIT | |
| SCHEMBL21592663 | 0.80 | DYRK1A (0.66) | MAP3K11DYRK1AKIT | |
| SCHEMBL21592491 | 0.80 | MAP4K1 (0.75) | MAP4K1IL2MAP3K11KITTNIK | |
| SCHEMBL28502370 | 0.79 | MAP4K1 (0.63) | MAP4K1IL2MAP3K11TNIK | |
| SCHEMBL21592585 | 0.79 | MAP4K1 (0.69) | MAP4K1IL2MAP3K11TNIK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112243439-A | Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof | 百济神州有限公司 | 2021-01-19 | — | — | CN | disclosed |
| WO-2019238067-A1 | PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF | BEIGENE, LTD. (KY) | 2019-12-19 | — | — | WO | disclosed |